R Gonsette

2.7k total citations · 1 hit paper
51 papers, 1.9k citations indexed

About

R Gonsette is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, R Gonsette has authored 51 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in R Gonsette's work include Multiple Sclerosis Research Studies (19 papers), Polyomavirus and related diseases (10 papers) and Peripheral Neuropathies and Disorders (3 papers). R Gonsette is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Polyomavirus and related diseases (10 papers) and Peripheral Neuropathies and Disorders (3 papers). R Gonsette collaborates with scholars based in Belgium, France and United States. R Gonsette's co-authors include P. Delmotte, Hans‐Peter Hartung, Hubert Kwieciński, Thomas Zwingers, Hilmar Krapf, Sean Morrissey, A. Guseo, Nikolaus König, Gilles Edan and E. Mauch and has published in prestigious journals such as The Lancet, Neurology and The Journal of Urology.

In The Last Decade

R Gonsette

46 papers receiving 1.8k citations

Hit Papers

Mitoxantrone in progressive multiple sclerosis: a placebo... 2002 2026 2010 2018 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial
    2002 669 citations Hans‐Peter Hartung, R Gonsette et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Gonsette Belgium 17 1.3k 547 545 409 295 51 1.9k
John N. Whitaker United States 17 696 0.6× 410 0.7× 199 0.4× 514 1.3× 418 1.4× 44 1.7k
Diego Franciotta Italy 15 844 0.7× 368 0.7× 351 0.6× 316 0.8× 509 1.7× 20 1.8k
Mariko Kita United States 16 1.1k 0.9× 420 0.8× 415 0.8× 386 0.9× 480 1.6× 31 1.9k
Carlo Avolio Italy 22 680 0.5× 286 0.5× 306 0.6× 398 1.0× 298 1.0× 75 1.8k
Philippe Truffinet France 18 2.0k 1.6× 946 1.7× 636 1.2× 290 0.7× 407 1.4× 68 2.6k
Yang Mao‐Draayer United States 26 890 0.7× 349 0.6× 374 0.7× 811 2.0× 547 1.9× 85 2.1k
Goeril Karlsson Switzerland 10 654 0.5× 264 0.5× 155 0.3× 754 1.8× 280 0.9× 30 1.6k
Katsuichi Miyamoto Japan 24 649 0.5× 702 1.3× 275 0.5× 443 1.1× 1.2k 4.0× 78 2.5k
Anne Waschbisch Germany 21 496 0.4× 195 0.4× 165 0.3× 420 1.0× 501 1.7× 46 1.5k
Tracy Stites United States 14 2.3k 1.9× 833 1.5× 583 1.1× 1.5k 3.8× 502 1.7× 21 3.4k

Countries citing papers authored by R Gonsette

Since Specialization
Citations

This map shows the geographic impact of R Gonsette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Gonsette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Gonsette more than expected).

Fields of papers citing papers by R Gonsette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Gonsette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Gonsette. The network helps show where R Gonsette may publish in the future.

Co-authorship network of co-authors of R Gonsette

This figure shows the co-authorship network connecting the top 25 collaborators of R Gonsette. A scholar is included among the top collaborators of R Gonsette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Gonsette. R Gonsette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gonsette, R. (2012). Self-tolerance in multiple sclerosis. Acta Neurologica Belgica. 112(2). 133–140. 33 indexed citations
2.
Gonsette, R, Christian Sindic, Marie D’hooghe, et al.. (2010). Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon β in relapsing- remitting Multiple Sclerosis (ASIIMS) trial. Multiple Sclerosis Journal. 16(4). 455–462. 47 indexed citations
3.
Gonsette, R. (2008). Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity. Journal of the Neurological Sciences. 274(1-2). 48–53. 225 indexed citations
4.
Gonsette, R. (2007). Advances in Treating Multiple Sclerosis. European Neurological Review. 18–18. 1 indexed citations
5.
Gonsette, R. (2007). Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis. Expert Opinion on Pharmacotherapy. 8(8). 1103–1116. 15 indexed citations
6.
Gonsette, R. (2004). New immunosuppressants with potential implication in multiple sclerosis. Journal of the Neurological Sciences. 223(1). 87–93. 20 indexed citations
7.
Gonsette, R. (2004). A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis. Expert Opinion on Pharmacotherapy. 5(4). 747–765. 13 indexed citations
8.
Gonsette, R. (2004). Pixantrone (BBR2778): a new immunosuppressant in multiple sclerosis with a low cardiotoxicity. Journal of the Neurological Sciences. 223(1). 81–86. 13 indexed citations
9.
Gonsette, R. (2004). A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis. Expert Opinion on Pharmacotherapy. 5(4). 747–765. 1 indexed citations
10.
Gonsette, R. (2003). Mitoxantrone in progressive multiple sclerosis: when and how to treat?. Journal of the Neurological Sciences. 206(2). 203–208. 38 indexed citations
11.
Hartung, Hans‐Peter, R Gonsette, Nikolaus König, et al.. (2002). Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. The Lancet. 360(9350). 2018–2025. 669 indexed citations breakdown →
12.
Dubois, Bénédicte, R Gonsette, Chris Dillen, & Alfons Billiau. (2001). Efficacy of a novel non-cardiotoxic aza-anthracenedione (BBR2778) in acute EAE. Multiple Sclerosis Journal. 7. 4 indexed citations
13.
Gonsette, R & P. Delmotte. (1984). Immunological and clinical aspects of multiple sclerosis : the proceedings of the XXV anniversary symposium of the Belgian Research Group for Multiple Sclerosis. 1 indexed citations
14.
Gonsette, R & P. Delmotte. (1984). Immunological and Clinical Aspects of Multiple Sclerosis. 19 indexed citations
15.
Gonsette, R, et al.. (1982). Modulation of immunity in multiple sclerosis: a double-blind levamisole-placebo controlled study in 85 patients. Journal of Neurology. 228(1). 65–72. 15 indexed citations
16.
Gonsette, R, et al.. (1978). [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].. PubMed. 78(3). 141–7. 1 indexed citations
17.
Delmotte, P. & R Gonsette. (1977). Biochemical findings in multiple sclerosis. Journal of Neurology. 215(1). 27–37. 105 indexed citations
18.
Fischgold, H, et al.. (1970). Radiculographie au Dimer X. Premiers résultats après 630 examens.. Neurochirurgie. 16(5). 4 indexed citations
19.
Gonsette, R, et al.. (1968). [A new technic of lumbosacral radiculography using a resorbable hydrosoluble medium without spinal anesthesia].. PubMed. 11(3). 141–5. 12 indexed citations
20.
Gonsette, R, et al.. (1956). [Contribution of EEG to diagnosis of lesions of the posterior cerebral fossa; survey of 131 verified cases].. PubMed. 95(6). 530–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John N. Whitaker Breakdown of academic impact, for papers by Diego Franciotta Breakdown of academic impact, for papers by Mariko Kita Breakdown of academic impact, for papers by Carlo Avolio Breakdown of academic impact, for papers by Philippe Truffinet Breakdown of academic impact, for papers by Yang Mao‐Draayer Breakdown of academic impact, for papers by Goeril Karlsson Breakdown of academic impact, for papers by Katsuichi Miyamoto Breakdown of academic impact, for papers by Anne Waschbisch Breakdown of academic impact, for papers by Tracy Stites
Rankless by CCL
2026